Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2006 | |
| Sales | 71,644 | 37,197 | 0 | 0 | 0 |
| Gross Profit | 71,644 | 37,197 | N/A | N/A | N/A |
| Operating Expenses | 90,859 | 51,663 | 30,396 | 16,212 | 0 |
| Operating Income | -19,215 | -14,466 | -30,396 | -16,212 | N/A |
| Other Income | 2,808 | 763 | 1,864 | 5,696 | 0 |
| Pre-tax Income | -16,407 | -13,703 | -28,532 | -10,516 | 0 |
| Income Tax | 36 | 0 | 0 | N/A | N/A |
| Net Income Continuous | -16,443 | -13,703 | -28,532 | -10,516 | N/A |
| Net Income | $-16,443 | $-13,703 | $-28,532 | $-10,516 | $N/A |
| EPS Basic Total Ops | -0.57 | -11.00 | -23.13 | -10.93 | N/A |
| EPS Basic Continuous Ops | -0.55 | -6.52 | -17.60 | -8.88 | N/A |
| EPS Diluted Total Ops | -0.57 | -11.00 | -23.13 | -10.93 | N/A |
| EPS Diluted Continuous Ops | -0.55 | -6.52 | -17.60 | -8.88 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.57 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-13,621 | $-12,195 | $-28,926 | $-15,106 | $N/A |